InvestorsHub Logo
Followers 1055
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

Re: tmeier post# 111

Friday, 07/01/2016 11:22:13 AM

Friday, July 01, 2016 11:22:13 AM

Post# of 363
"one step closer to NDA submission and market launch",actually Material Events/catalysts could hit before NDA submission: a commercialization Agreement and a second patent granted. imo

The company has completely zero debt and trading way under Cash on hand.Not to mention that Celebrex(Pfizer Drug) has major risks while kitov has an improved Celebrex .folks might drop Celebrex overnight and switch to Kitov drug and not worry about side affects. with the improved celebrex Pfizer could easily pass $2.4B even $3B sales IMO. also analysts predicted a blockbaster potential in the US alone.

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.